Skip to main content
SpringerLink
Log in

Inhibition of platelet aggregation by a new stable prostacyclin introduced in therapy of patients with progressive scleroderma

  • Short Communications
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Allen JA, O'Reilly MJ (1981) Treatment of severe Raynaud's phenomenon with prostaglandin E1. Ir J Med Sci 150:190–191

    Google Scholar 

  2. Baron M, Skrinskas G (1982) Prostaglandin-E1 therapy for digital ulcers in scleroderma. Can Med Assoc J 126:42–45

    Google Scholar 

  3. Belch JJF, Drury JK, Capell H (1983) Intermittent epoprostenerol (prostacyclin) infusion in patients with Raynaud's syndrome. Lancet 1:313–319

    Google Scholar 

  4. Breddin K, Grun H, Krywanek HJ, Schremmer WP (1975) Zur Messung der spontanen Thrombocytenaggregation. Plättchenaggregationstest. III. Methodik. Klin Wochenschr 53:81–87

    Google Scholar 

  5. Dowd PM, Kovacs IB (1981) Effects of prostaglandins I2 and E1 on red cell deformability in patients with Raynaud's phenomenon and systemic sclerosis. Br Med J [Clin Res] 283:350–354

    Google Scholar 

  6. Dowd PM, Martin MFR, Cooke ED, Bowcock S, Jones R, Dieppe PA, Kirby JD (1982) Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PG I2). Brit J Dermatol 106:81–89

    Google Scholar 

  7. Kahan A, Weber S, Amor B, Menkes CJ (1983) Epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. Lancet 1:538

    Google Scholar 

  8. Kaukinen S, Pessi T, Ylitalo P, Krais T, Vapaatalo H (1984) Clinical study of ZK 36374 — a new stable prostacyclin analogue for treatment of peripheral vascular disease (ZK 36374 in peripheral vasculare disease). Progr Card Vasc Dis (in press)

  9. Keller J, Kaltenecker A, Schricker KT, Krais T, Gevatter M, Hornstein OP (1984) Behandlung des Raynaud-Phänomens bei Sklerodermiepatienten mit einem neuen stabilen Prostacyclinderivat. Dtsch Med Wochenschr 109:1433–1438

    Google Scholar 

  10. Krais T (1982) Summary of the results of preclinical studies and phase-I trials with the prostacyclin analogue ZK 36374. Reprint Schering AG, Berlin

  11. Martin MR, Dowd PM (1981) Prostaglandin-E1 infusion for vascular insufficiency in progressive systemic sclerosis. Ann Rheum Dis 40:350–354

    Google Scholar 

  12. Martin MF, Tooke JE (1982) Effects of prostaglandin E1 on microvascular haemodynamics in progressive systemic sclerosis. Br med [Clin Res] 285:1688–1690

    Google Scholar 

  13. Silberbauer K, Sinzinger H, Punzengruber C (1982) Longterm prostacyclin (PGI2) therapy in peripheral arterial disease — influence in some vascular and platelet regulation mechanisms. Prostaglandins Clin Med Cardiovasc Thromb Dis 27:233–244

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Erlangen-Nürnberg, Hartmannstraße 14, D-8520, Erlangen, Germany

    J. Keller, A. Kaltenecker & O. P. Hornstein

  2. Department of Hematology, University of Erlangen-Nürnberg, Hartmannstraße 14, D-8520, Erlangen, Germany

    K. T. Schricker & B. Neidhardt

Authors
  1. J. Keller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Kaltenecker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. T. Schricker
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Neidhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. O. P. Hornstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keller, J., Kaltenecker, A., Schricker, K.T. et al. Inhibition of platelet aggregation by a new stable prostacyclin introduced in therapy of patients with progressive scleroderma. Arch Dermatol Res 277, 323–325 (1985). https://doi.org/10.1007/BF00509089

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00509089

Key words

Search

Navigation